TY - JOUR
T1 - Contact Dermatitis
T2 - A Practice Parameter-Update 2015
AU - Fonacier, Luz
AU - Bernstein, David I.
AU - Pacheco, Karin
AU - Holness, D. Linn
AU - Blessing-Moore, Joann
AU - Khan, David
AU - Lang, David
AU - Nicklas, Richard
AU - Oppenheimer, John
AU - Portnoy, Jay
AU - Randolph, Christopher
AU - Schuller, Diane
AU - Spector, Sheldon
AU - Tilles, Stephen
AU - Wallace, Dana
N1 - Funding Information:
Disclosure of potential conflict of interest: L. Fonacier has received research and educational grants (made to Winthrop University Hospital) from Genentech, Merck, and Baxter; is in the Speaker's Bureau/Honoraria of Baxter; and is on the Board of Directors, Joint Council of Allergy, Asthma and Immunology (JCAAI) 2012-2015. D. Bernstein is the consultant in Merck, Genentech, Proctor and Gamble, Sanofi, and TEVA; and has received research grants from Amgen, GlaxoSmithKline, Greer, Johnson & Johnson, Merck, Teva, Pfizer, Genentech, Array, Cephalon, Novartis, Boeringer Ingelheim, and Medimmune. The rest of the authors declare that they have no relevant conflicts of interest.
Publisher Copyright:
© 2015 American Academy of Allergy, Asthma & Immunology.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - This parameter was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Contact Dermatitis: A Practice Parameter-Update 2015." This is a complete and comprehensive document at the current time. The medical environment is changing and not all recommendations will be appropriate or applicable to all patients. Because this document incorporated the efforts of many participants, no single individual, including members serving on the Joint Task Force, are authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information or interpretation of this practice parameter by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by the pharmaceutical industry in drug development or promotion. Previously published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology.
AB - This parameter was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Contact Dermatitis: A Practice Parameter-Update 2015." This is a complete and comprehensive document at the current time. The medical environment is changing and not all recommendations will be appropriate or applicable to all patients. Because this document incorporated the efforts of many participants, no single individual, including members serving on the Joint Task Force, are authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information or interpretation of this practice parameter by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by the pharmaceutical industry in drug development or promotion. Previously published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology.
KW - Allergen
KW - Allergic contact dermatitis
KW - Contact dermatitis
KW - Guideline
KW - Occupational
KW - Parameter
KW - Patch testing
KW - Sensitizer
UR - http://www.scopus.com/inward/record.url?scp=84929177043&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929177043&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2015.02.009
DO - 10.1016/j.jaip.2015.02.009
M3 - Article
C2 - 25965350
AN - SCOPUS:84929177043
SN - 2213-2198
VL - 3
SP - S1-S39
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 3
ER -